Company 4DMedical Limited

Equities

4DX

AU0000095416

Advanced Medical Equipment & Technology

Delayed Australian S.E. 23:28:14 2024-05-15 EDT 5-day change 1st Jan Change
0.625 AUD +1.63% Intraday chart for 4DMedical Limited +9.01% -15.38%

Business Summary

4DMedical Limited is an Australia-based medical technology company. Through its flagship patented XV Technology, the Company enables physicians to understand regional airflow in the lungs and identify respiratory deficiencies earlier and with greater sensitivity as they breathe. This technology powers its FDA-cleared XV Lung Ventilation Analysis Software (XV LVA), which is a modality to dynamically quantify ventilation throughout the lungs, and its Computed Tomography-enabled counterpart software, CT LVAS. XV LVAS and CT LVAS reports are prepared using the Company’s software as a service (SaaS) delivery model using existing hospital imaging equipment or the Company's XV Scanner. It initiated the commercial rollout of XV LVAS with I-MED Radiology Network (I-MED), which is a diagnostic imaging provider with approximately 250 clinics nationwide. The Company provides its lung imaging technology to other selected clinics across the I-MED network.

Number of employees: 131

Sales per Business

AUD in Million2022Weight2023Weight Delta
Lease Income
60.7 %
- - 0 60.7 % -
Software Licenses
27.3 %
0 13.6 % 0 27.3 % +36.74%
Services
6.3 %
0 4.4 % 0 6.3 % -2.35%
Support and Maintenance
5.7 %
0 3.4 % 0 5.7 % +15.00%

Sales per region

AUD in Million2022Weight2023Weight Delta
Australia
75.5 %
0 9.5 % 1 75.5 % +441.09%
United States
24.5 %
1 90.5 % 0 24.5 % -81.56%

Managers

Managers TitleAgeSince
Chief Executive Officer - 12-11-30
Director of Finance/CFO - 22-07-24
Chief Tech/Sci/R&D Officer - -
Chief Tech/Sci/R&D Officer - 20-05-31
Chief Tech/Sci/R&D Officer - 16-11-30
Director/Board Member - 17-09-30
Public Communications Contact - -
Corporate Officer/Principal - -
Corporate Officer/Principal - 22-12-07
General Counsel - 20-12-31

Members of the board

Members of the board TitleAgeSince
Director/Board Member - -
Director/Board Member - 17-08-31
Director/Board Member 60 23-09-24
Chief Executive Officer - 12-11-30
Chairman - 19-11-30
Director/Board Member - 17-09-30

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 390,883,800 282,944,517 ( 72.39 %) 0 72.39 %

Shareholders

NameEquities%Valuation
65,701,465 16.79 % 26 M $
Perennial Value Management Ltd.
3.755 %
14,695,142 3.755 % 6 M $
Ryder Investment Management Pty Ltd.
1.607 %
6,290,475 1.607 % 2 M $
Alex Petrou
0.6348 %
2,484,471 0.6348 % 967 975 $
2,470,000 0.6311 % 962 337 $
Netwealth Investments Ltd.
0.5980 %
2,340,650 0.5980 % 911 941 $
1,925,352 0.4919 % 750 136 $
1,841,379 0.4705 % 717 420 $
Endless Smiles Pty Ltd.
0.3833 %
1,500,000 0.3833 % 584 415 $
Dev Jayram
0.3662 %
1,433,262 0.3662 % 558 413 $
NameEquities%Valuation
DFA Australia Ltd.
0.0470 %
10,412 0.0470 % 710 $

Company contact information

4DMedical Ltd.

Level 7 700 Swanston Street

3053, Carlton

+

http://www.4dmedical.com
address 4DMedical Limited(4DX)
  1. Stock Market
  2. Equities
  3. 4DX Stock
  4. Company 4DMedical Limited
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW